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In this issue of Blood, Ebert et al conclude that endothelial cell (EC) tissue 
factor (TF) activity induces a prothrombotic state in mice that lack the anti-
oxidant paraoxonase-2 (PON2).1
Because of its potent procoagulant ac-
tivity, TF gene expression and activity are
tightly regulated to maintain hemostasis
while preventing thrombosis. TF is consti-
tutively expressed by perivascular cells,
such as vascular smooth muscle cells (see
figure panel A).2 In contrast, unstimulated
blood monocytes and ECs do not express
TF. However, they express TF after activa-
tion as part of the host defense system.
TF activity is also regulated posttransla-
tionally with several proposed mecha-
nismsof de-encryption, including interaction
with phosphatidylserine and oxidation of
an allosteric disulfide bond (see figure
panel B).2
The PON family of antioxidants consists
of 3 members: PON1, PON2, and PON3.3
PON1 and PON3 are expressed by the liver
and bind to high density lipoprotein and
prevent its oxidation. In contrast, PON2
is expressed by macrophages, vascular
smooth muscle cells, and ECs (see figure
panel A).3 Interestingly, PON2-deficient
mice developed atherosclerosis when fed
aWestern diet, and this was attributed to a
deficiency of PON2 in macrophages.4
Ebert and colleagues observed numer-
ous abnormalities in PON22/2mice, includ-
ing increased reactive oxygen species in
the aorta; increased levels of interleukin-6
(IL-6) in the plasma; elevated plasma
levels of factor VIII (FVIII), FIX, and FXI
activities; shortened prothrombin time;
shortened activated partial thrombo-
plastin time; and a shortened tail bleed-
ing time. Furthermore, they found that
platelets expressed PON2, and deficient
cells had increased reactive oxygen spe-
cies, increased volume, and increased
binding of annexin V. In vitro studies with
primary lung ECs showed increased basal
levels of a variety of inflammatory medi-
ators and a decrease in the anticoagulant
TF pathway inhibitor. Surprisingly, the ex-
pression of other markers of EC activation,
such as ICAM-1, E-selectin, or VCAM-1, were
not increased. Primary lung PON22/2 ECs
expressed TF messenger RNA and protein
at similar levels to those in wild-type cells
but had increased levels of TF activity (see
figure panel B).
Because PON2 is expressed by macro-
phages, vascular smooth muscle cells,
and ECs, it was important to determine
which cell types contributed to the dif-
ferent phenotypes in PON22 /2 mice.
Importantly, an anti-mouse TF antibody
normalized the prothrombotic phenotype,
which indicates that the prothrombotic
phenotype was due to TF. Bone marrow
transplantation experiments showed that
the prothrombotic phenotype tracked
with PON2 deficiency in nonhemato-






















• Elevated levels of FVIII, FIX
and FXI activities
• Shortened PT and aPTT
• Shortened tail bleeding
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(A) TF is constitutively expressed by vascular smoothmuscle cells (VSMCs) and activatedmonocytes and ECs. PON2
is expressed by macrophages, VSMCs, and ECs. (B) Loss of PON2 leads to increased levels of reactive oxygen
species (ROS) in ECs and de-encryption of TF. In addition, increased levels of ROSmay induce TF gene expression.
Increased levels of EC TF activity are proposed to mediate the prothrombotic state in PON22/2 mice, which was
assessed by measuring plasma FVIII, FIX, and FXI activities, prothrombin time (PT), activated partial thromboplastin
time (aPTT), and tail bleeding. The antioxidant N-acetylcysteine (NAC) and an anti-mouse antibody (Ab) normalize
the prothrombotic state in PON22/2 mice. KO, knockout.
variability in the hemostatic parameters
in these experiments. It is also surprising that
platelets did not contribute to the short-
ened tail bleeding. Finally, re-expression
of PON2 in EC and hematopoietic cells
normalized the prothrombotic phenotype.
These results led the authors to conclude
that the prothrombotic phenotype in
PON22/2mice is the result of an increase
in EC TF activity but not the result of
changes in TF expression in hemato-
poietic cells or vascular smooth muscle
cells.
Unstimulated ECs express several antico-
agulants, such as TF pathway inhibitor, EC
protein C receptor, and thrombomodulin,
to prevent activation of coagulation. Ac-
tivated ECs become procoagulant be-
cause of the downregulation of ECprotein
C receptor and thrombomodulin and the
induction of TF. Although TF expression is
readily detectable in cultured human and
murine ECs, it has been difficult to dem-
onstrate in vivo.2 The limited examples of
TF staining of ECs include splenic micro-
vascular ECs and arterial branching areas
in septic baboons, ECs of the glomerulus
of endotoxemic mice, and ECs in the
lungs of sickle cell mice.5-8 It is possible
that someor all of this TF staining is a result
of the binding of TF-positive monocyte-
derived microvesicles to activated ECs.
We and others have used genetic ap-
proaches to study the role of EC TF in the
activation of coagulation in different dis-
eases.We found that deletion of ECTFdid
not affect the activation of coagulation in
a mouse endotoxemia model.9 Similarly,
deletion of EC TF did not affect the acti-
vation of coagulation but reduced IL-6
expression in a mouse model of sickle cell
disease.10 Song and colleagues7 gener-
ated mice with inducible expression of a
degradation resistant form of IkBa in ECs
and found that it blocked the induction
of TF in ECs in the glomerulus of endo-
toxemic mice. They could not determine
the impact of preventing EC TF expression
on the activation of coagulation because
the mutant form of IkBa also prevented
the downregulation of EC protein C re-
ceptor and thrombomodulin.
The study by Ebert et al has several limi-
tations. One must be cautious when ex-
trapolating data from in vitro studies
to explain a complex phenotype in mice.
For instance, primary lung ECs from both
PON22/2 and wild-type mice expressed
high TF levels, which suggests that the
cells were activated. Indeed, no direct
data were presented to show EC TF ex-
pression in PON22/2 mice. The role of EC
TF in the prothrombotic state in PON22/2
mice could be directly examined by
crossing PON22/2 mice with mice that
lacked EC TF. The model presented by
Ebert et al shows that the absence of
PON2 only leads to de-encryption of EC
TF. However, it seems that increased re-
active oxygen species may also induce
EC TF gene expression (see figure). The
prothrombotic state of PON22/2 mice
was assessed by using plasma-based co-
agulation assays, which are not routinely
used tomonitor activation of coagulation.
Typically, a prothrombotic state in mice
is associated with increased levels of
thrombin-antithrombin complexes and
decreased levels of fibrinogen and fi-
brin deposition. Interestingly, levels of
thrombin-antithrombin complexes were
not increased in PON22/2 mice. Fur-
thermore, the prothrombotic state was
functionally evaluated by using tail bleed-
ing rather than thrombosis models. The
current data do not exclude the possi-
bility that PON2 deficiency in ECs leads
to increased vascular permeability that
would expose subendothelial TF to blood
and contribute to the prothrombotic state.
Finally, the investigators acknowledge
the fact that a reduction of EC protein C
receptor and thrombomodulin could also
contribute to the prothrombotic state ob-
served in PON22/2 mice. Although the
study by Ebert et al is provocative, it seems
premature to suggest that PON2 and EC
TF activity represent new targets for anti-
coagulant and anti-inflammatory strategies.
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